Mark D. Potter
Impact in
- Hematology top 5%
- Acute Myeloid Leukemia Research
- Genetics top 5%
- Genetic Associations and Epidemiology
- Genomics and Rare Diseases
- Genetics and Neurodevelopmental Disorders
- Genomic variations and chromosomal abnormalities
Papers in
-
- Protein Degradation and Inhibitors 2
- Genomics and Chromatin Dynamics 2
-
- Chronic Myeloid Leukemia Treatments 4
- Acute Myeloid Leukemia Research 3
- Multiple Myeloma Research and Treatments 3
- Co-authors
- Gerard C. Grosveld (6 shared papers)Tamás Oravecz (1 shared paper)Konstantin V. Salojin (1 shared paper)Hannes Pétursson (3 shared papers)Jon Brynjolfsson (3 shared papers)Robin Sherrington (3 shared papers)Keith E. Dudleston (1 shared paper)H. Gurling (1 shared paper)
- Journals
- Blood (4 papers)Mammalian Genome (2 papers)Cancer Research (1 paper)Schizophrenia Bulletin (1 paper)JNCI Journal of the National Cancer Institute (1 paper)
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
Mark D. Potter
23 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 98
- Hematology 167
- Genetics 367
- Immunology 206
- Psychiatry and Mental health 145
- Molecular Biology 611
Countries citing papers authored by Mark D. Potter
This map shows the geographic impact of Mark D. Potter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark D. Potter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark D. Potter more than expected).
Fields of papers citing papers by Mark D. Potter
This network shows the impact of papers produced by Mark D. Potter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark D. Potter. The network helps show where Mark D. Potter may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark D. Potter, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1988 | 402 | |
| 2 | 2006 | 286 | |
| 3 | 2002 | 86 | |
| 4 | 1994 | 84 | |
| 5 | 2000 | 73 | |
| 6 | 2000 | 68 | |
| 7 | 2003 | 50 | |
| 8 | 2000 | 44 | |
| 9 | 2000 | 42 | |
| 10 | 2005 | 35 | |
| 11 | 1998 | 20 | |
| 12 | 2004 | 20 | |
| 13 | 1990 | 16 | |
| 14 | 1995 | 16 | |
| 15 | 1995 | 16 | |
| 16 | 1997 | 16 | |
| 17 | 1993 | 14 | |
| 18 | A novel c-myc-activating reciprocal T(12;15) chromosomal translocation juxtaposes S alpha to Pvt-1 in a mouse plasmacytoma. | 1994 | 9 |
| 19 | Retroviral enhancer insertion 5' of c-myc in two translocation-negative mouse plasmacytomas upregulates c-myc expression to different extents. | 1993 | 7 |
| 20 | 1989 | 6 |
About Mark D. Potter
Mark D. Potter is a scholar working on Molecular Biology, Hematology, Immunology, Public Health, Environmental and Occupational Health and Genetics, having authored 23 papers that have together received 1.3k indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (4 papers), Chronic Myeloid Leukemia Treatments (4 papers), Acute Myeloid Leukemia Research (3 papers), T-cell and B-cell Immunology (3 papers), Multiple Myeloma Research and Treatments (3 papers), Protein Degradation and Inhibitors (2 papers), Hemoglobinopathies and Related Disorders (2 papers) and Genomics and Chromatin Dynamics (2 papers). The work is most often cited by research in Hematology (167 citations), Genetics (367 citations), Immunology (206 citations), Psychiatry and Mental health (145 citations) and Molecular Biology (611 citations). Mark D. Potter has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Gerard C. Grosveld, Tamás Oravecz, Konstantin V. Salojin, Hannes Pétursson, Jon Brynjolfsson, Robin Sherrington, Keith E. Dudleston, H. Gurling, B. M. Barraclough and John J. Wasmuth. Their work appears in journals such as Blood, Mammalian Genome, Cancer Research, Schizophrenia Bulletin and JNCI Journal of the National Cancer Institute.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.